103 related articles for article (PubMed ID: 2456400)
1. Combined therapy with 5-azacytidine and hydrocortisone in glucocorticoid-sensitive and -resistant mouse P1798 lymphosarcoma.
Chi CW; Ip MM
J Natl Cancer Inst; 1988 Aug; 80(12):912-8. PubMed ID: 2456400
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of cortisol-sensitive and -resistant P1798 mouse lymphosarcoma cell lines.
Chi CW; Sykes D; Ip MM
Mol Cell Endocrinol; 1989 Apr; 62(2):167-76. PubMed ID: 2744225
[TBL] [Abstract][Full Text] [Related]
3. The truncated glucocorticoid receptor in the P1798 mouse lymphosarcoma is associated with resistance to glucocorticoid lysis but not to other glucocorticoid-induced functions.
Ip MM; Shea WK; Sykes D; Young DA
Cancer Res; 1991 Jun; 51(11):2786-96. PubMed ID: 1674446
[TBL] [Abstract][Full Text] [Related]
4. Nonmutational alteration in glucocorticoid sensitivity of lymphosarcoma P1798.
Davis JM; Chan AK; Thompson EA
J Natl Cancer Inst; 1980 Jan; 64(1):55-62. PubMed ID: 6928047
[TBL] [Abstract][Full Text] [Related]
5. Nuclear binding of steroid-receptor complex to lymphosarcoma P1798 resistant and sensitive cells and effect of concanavalin A on receptor levels.
McPartland RP; Milholland RJ; Rosen F
Cancer Res; 1977 Dec; 37(12):4256-60. PubMed ID: 579163
[TBL] [Abstract][Full Text] [Related]
6. Effect of sodium butyrate on glucocorticoid-sensitive and -resistant P1798 lymphosarcoma.
Chang YF; Wu LH; Liu TY; Yang JC; Chi CW
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jan; 49(1):1-5. PubMed ID: 1312378
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid receptors and mechanism of resistance in the cortisol-sensitive and -resistant lines of lymphosarcoma P1798.
Kaiser N; Milholland RJ; Rosen F
Cancer Res; 1974 Mar; 34(3):621-6. PubMed ID: 4359883
[No Abstract] [Full Text] [Related]
8. Isolation and characterization of lymphosarcoma P1798 variants selected for resistance to the cytolytic effects of glucocorticoids in vivo and in culture.
Wood KM; Thompson EA
Mol Cell Endocrinol; 1984 Sep; 37(2):169-80. PubMed ID: 6092172
[TBL] [Abstract][Full Text] [Related]
9. Effect of glucocorticoid hormones in vitro on the structural integrity of nuclei in corticosteroid-sensitive and -resistant lines of lymphosarcoma P1798.
Nicholson ML; Young DA
Cancer Res; 1978 Nov; 38(11 Pt 1):3673-80. PubMed ID: 581273
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid effects of lymphosarcoma P1798 on DNA replication and growth of subcutaneous tumors in mice.
Thompson EA; Moore WM; Sawyer RH
J Natl Cancer Inst; 1980 Aug; 65(2):477-83. PubMed ID: 6931263
[TBL] [Abstract][Full Text] [Related]
11. Identification and localization of steroid-binding and nonsteroid-binding forms of the glucocorticoid receptor in the mouse P1798 lymphosarcoma.
Rowan BG; Ip MM
J Steroid Biochem Mol Biol; 1995 May; 52(5):437-50. PubMed ID: 7748809
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glucose uptake in lymphosarcoma P1798 by cortisol and its relationship to the biosynthesis of deoxyribonucleic acid.
Rosen JM; Fina JR; Milholland J; Rosen F
J Biol Chem; 1970 Apr; 245(8):2074-80. PubMed ID: 5467455
[No Abstract] [Full Text] [Related]
13. Selective effect of cortisol on deoxyribonuclease II activity of lymphosarcoma P1798.
Raina PN; Rosen F
Arch Int Pharmacodyn Ther; 1969 Nov; 182(1):14-23. PubMed ID: 5395574
[No Abstract] [Full Text] [Related]
14. Difference in the number of insulin binding sites between cortisol-sensitive and cortisol-resistant lymphoma P1798 cells.
Roldán A; Stevens J; Hollander VP
Proc Soc Exp Biol Med; 1976 Apr; 151(4):711-5. PubMed ID: 4812
[TBL] [Abstract][Full Text] [Related]
15. Silencing of metallothionein-I gene in mouse lymphosarcoma cells by methylation.
Majumder S; Ghoshal K; Li Z; Bo Y; Jacob ST
Oncogene; 1999 Nov; 18(46):6287-95. PubMed ID: 10597227
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and molecular characterization of the glucocorticoid receptor of lymphosarcoma P1798 variants.
Lucas KL; Barbour KW; Housley PR; Thompson EA
Mol Endocrinol; 1988 Mar; 2(3):291-9. PubMed ID: 3398856
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid binding properties of mouse thymic lymphosarcoma cell populations selected for resistance to the cytolytic effects of glucocorticoids in vivo.
Chan AK; Thompson EA
J Natl Cancer Inst; 1983 Sep; 71(3):579-82. PubMed ID: 6577232
[TBL] [Abstract][Full Text] [Related]
18. Charge heterogeneity in wildtype and variant glucocorticoid receptors.
Rowan BG; Ip MM
Mol Cell Endocrinol; 1995 Jan; 107(1):41-54. PubMed ID: 7796934
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical differences between glucocorticoid-binding components from the corticoid-sensitive and -resistant strains of mouse lymphoma P1798.
Stevens J; Stevens YW
Cancer Res; 1979 Oct; 39(10):4011-21. PubMed ID: 476639
[TBL] [Abstract][Full Text] [Related]
20. Differential binding of mutant glucocorticoid receptors to the glucocorticoid response element of the tyrosine aminotransferase gene.
Rowan BG; Ip MM
J Steroid Biochem Mol Biol; 1996 May; 58(2):147-62. PubMed ID: 8809196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
